Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 326

1.

Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis.

Freie B, Li X, Ciccone SL, Nawa K, Cooper S, Vogelweid C, Schantz L, Haneline LS, Orazi A, Broxmeyer HE, Lee SH, Clapp DW.

Blood. 2003 Dec 1;102(12):4146-52. Epub 2003 Jul 10.

2.

A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint.

Freie BW, Ciccone SL, Li X, Plett PA, Orschell CM, Srour EF, Hanenberg H, Schindler D, Lee SH, Clapp DW.

J Biol Chem. 2004 Dec 3;279(49):50986-93. Epub 2004 Sep 17.

3.

Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.

Noll M, Battaile KP, Bateman R, Lax TP, Rathbun K, Reifsteck C, Bagby G, Finegold M, Olson S, Grompe M.

Exp Hematol. 2002 Jul;30(7):679-88.

PMID:
12135664
4.
5.

The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality.

Pang Q, Christianson TA, Keeble W, Diaz J, Faulkner GR, Reifsteck C, Olson S, Bagby GC.

Blood. 2001 Sep 1;98(5):1392-401.

6.

Functional correction of FA-C cells with FANCC suppresses the expression of interferon gamma-inducible genes.

Fagerlie SR, Diaz J, Christianson TA, McCartan K, Keeble W, Faulkner GR, Bagby GC.

Blood. 2001 May 15;97(10):3017-24.

7.
8.

Tumor necrosis factor-alpha and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice.

Otsuki T, Nagakura S, Wang J, Bloom M, Grompe M, Liu JM.

J Cell Physiol. 1999 Apr;179(1):79-86.

PMID:
10082135
9.
10.
11.

Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc-/- hematopoietic stem cells and decreases the risk of clonal evolution.

Haneline LS, Li X, Ciccone SL, Hong P, Yang Y, Broxmeyer HE, Lee SH, Orazi A, Srour EF, Clapp DW.

Blood. 2003 Feb 15;101(4):1299-307. Epub 2002 Oct 10.

12.
13.

Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene.

Whitney MA, Royle G, Low MJ, Kelly MA, Axthelm MK, Reifsteck C, Olson S, Braun RE, Heinrich MC, Rathbun RK, Bagby GC, Grompe M.

Blood. 1996 Jul 1;88(1):49-58.

14.

Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.

Yamashita T, Nakahata T.

Int J Hematol. 2001 Jul;74(1):33-41. Review.

PMID:
11530803
15.

The Fanconi anemia proteins functionally interact with the protein kinase regulated by RNA (PKR).

Zhang X, Li J, Sejas DP, Rathbun KR, Bagby GC, Pang Q.

J Biol Chem. 2004 Oct 15;279(42):43910-9. Epub 2004 Aug 6.

16.

In vivo administration of interferon gamma does not cause marrow aplasia in mice with a targeted disruption of FANCC.

Kurre P, Anandakumar P, Grompe M, Kiem HP.

Exp Hematol. 2002 Nov;30(11):1257-62.

PMID:
12423678
17.

Fanconi anemia type C-deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control.

Li X, Plett PA, Yang Y, Hong P, Freie B, Srour EF, Orschell CM, Clapp DW, Haneline LS.

Blood. 2003 Sep 15;102(6):2081-4. Epub 2003 May 22.

18.

Hematopoietic stem cells from fancc(-/-) mice have lower growth and differentiation potential in response to growth factors.

Aubé M, Lafrance M, Charbonneau C, Goulet I, Carreau M.

Stem Cells. 2002;20(5):438-47.

19.

Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.

Adachi D, Oda T, Yagasaki H, Nakasato K, Taniguchi T, D'Andrea AD, Asano S, Yamashita T.

Hum Mol Genet. 2002 Dec 1;11(25):3125-34.

PMID:
12444097
20.

Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells.

Rathbun RK, Faulkner GR, Ostroski MH, Christianson TA, Hughes G, Jones G, Cahn R, Maziarz R, Royle G, Keeble W, Heinrich MC, Grompe M, Tower PA, Bagby GC.

Blood. 1997 Aug 1;90(3):974-85.

Supplemental Content

Support Center